Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs FCUV✓SelectedUSD · FCUVGSK vs FCUV performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs FCUV

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.3%
FCUV return
-96.0%
Excess return
+103.3%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioFCUVExcessAlpha
1D-2.3%-3.0%+0.6%-2.3%
7D-3.0%+56.3%-59.3%-3.0%
30D+0.4%+29.4%-29.0%+0.4%
3M-1.2%-29.4%+28.2%-1.1%
6M+0.9%+35.8%-34.9%+1.1%
YTD+4.0%-85.9%+89.9%+3.2%
1Y+7.3%-95.7%+103.0%+7.1%
All+7.3%-96.0%+103.3%+7.1%

Cumulative growth

Daily Returns

Daily percentage return beside FCUV.

Daily Out/Under-Performance

Portfolio return minus FCUV return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FCUV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded FCUV wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling